Credit Suisse Investment Banking Pitch Book

Premiums paid on selected precedent transactions 100% cash consideration, transaction value >$2 billion ($ in millions) Ann. Date Target 09/03/12 Medicis Pharmaceutical Corp 07/23/12 Nexen Inc. 07/09/12 Amerigroup Corp 07/01/12 Lincare Holdings Inc 06/29/12 Amylin Pharmaceuticals Inc 04/19/12 Human Genome Sciences Inc 01/07/12 Inhibitex Inc 09/12/11 NetLogic Microsystems 08/15/11 Motorola Mobility Holdings Inc 07/14/11 Petrohawk Energy Corp 06/23/11 Southern Union Co 06/13/11 The Timberland Co 06/06/11 Temple-Inland Inc 05/06/11 Warner Music Group Corp 05/04/11 Varian Semiconductor Equip 04/04/11 National Semiconductor Corp 03/28/11 GSI Commerce Inc 02/07/11 Beckman Coulter Inc 11/30/10 Baldor Electric Co 11/15/10 Bucyrus International Inc 10/12/10 King Pharmaceuticals Inc 08/23/10 3PAR Inc 08/19/10 McAfee Inc 05/12/10 Sybase Inc 03/01/10 OSI Pharmaceuticals Inc 02/28/10 Millipore Corp 11/11/09 3Com Corp 09/21/09 Perot Systems Corp 04/20/09 Sun Microsystems Inc 10/02/08 Atmel Corp 07/14/08 Republic Services Inc 07/14/08 Duvernay Oil Corp 07/10/08 Rohm & Haas Co 05/13/08 Electronic Data Systems Corp 03/03/08 Diebold Inc 02/21/08 Choice Point Inc 12/10/07 Adams Respiratory Therapeutics 11/26/07 Genlyte Group Inc 10/15/07 Tektronix Inc Source: Note: (1) Acquiror Valeant Pharm Intl Inc CNOOC WellPoint Inc Credit SuisSE Linde AG Bristol-Myers Squibb Co GlaxoSmithKline PLC Bristol-Myers Squibb Co Broadcom Corp. Google Inc BHP Billiton PLC The Williams Cos Inc VF Enterprises Inc International Paper Co Access Industries Inc Applied Materials Texas Instruments Inc eBay Inc. Danaher Corp ABB Ltd Caterpillar Inc Pfizer Inc Hewlett-Packard Co Intel SAP Astellas Pharma Inc Merck KGaA Hewlett-Packard Co Dell Inc Oracle Corp Microchip Technology Inc Waste Management Inc Royal Dutch Shell Dow Chemical Co Hewlett-Packard Co United Technologies Corp Reed Elsevier Group PLC Reckitt Benckiser PLC Philips Holding USA Inc Danaher Corp SDC Platinum, FactSet Research Systems. Highlighted deals represent E&P transactions. Premium to unaffected spot prices. Trans. Value $3,074 17,743 4,852 3,689 7,183 2,910 2,524 3,678 11,878 15,068 5,520 2,181 3,582 3,306 4,715 6,360 2,279 5,782 4,188 7,453 3,566 2,065 7,828 6,149 3,100 6,127 3,183 3,628 7,305 2,249 7,016 5,838 15,513 12,565 2,632 3,790 2,267 2,810 2,956 1-Day 39.4% 61.2% 43.0% 64.3% 101.4% 98.7% 163.4% 56.7% 63.5% 65.0% 55.7% 43.4% 47.5% 74.8% 55.4% 77.7% 50.9% 46.3% 40.8% 32.2% 40.4% 82.9% 60.4% 56.4% 55.3% 50.0% 38.8% 67.5% 42.0% 52.4% 32.6% 42.0% 74.0% 32.6% 65.8% 48.5% 37.4% 52.4% 34.1% 5-Day 34.5% 66.0% 39.6% 61.2% 103.1% 92.3% 137.7% 67.3% 85.8% 57.7% 50.2% 45.8% 30.6% 56.8% 34.5% 73.3% 49.3% 42.8% 41.5% 27.7% 40.3% 83.3% 60.2% 53.0% 55.2% 54.9% 44.7% 74.6% 48.0% 37.4% 29.3% 51.2% 72.3% 29.8% 55.3% 46.0% 38.6% 46.7% 31.9% 10-Day 34.0% 67.1% 45.8% 66.7% 97.7% 79.9% 137.4% 74.0% 82.2% 57.1% 48.6% 32.2% 38.8% 53.1% 46.0% 78.6% 59.0% 50.5% 42.7% 36.5% 43.5% 223.9% 47.6% 50.5% 62.1% 57.5% 45.2% 80.1% 11.9% 31.6% 24.6% 37.0% 59.0% 31.9% 60.4% 52.4% 45.0% 43.9% 36.1% Premium to (¹) 20-Day 33.5% 73.7% 47.2% 82.2% 81.4% 85.1% 86.2% 58.4% 84.4% 63.6% 55.9% 27.6% 31.2% 50.3% 30.0% 70.2% 40.7% 49.0% 50.6% 23.6% 53.2% 244.8% 52.0% 38.1% 68.0% 51.1% 38.8% 76.5% 17.3% 26.3% 9.3% 34.3% 53.3% 47.2% 47.4% 55.3% 39.0% 65.7% 19.4% 30-Day 33.1% 74.5% 47.2% 81.5% 73.5% 75.9% 86.2% 58.4% 89.4% 62.1% 58.9% 26.9% 33.2% 50.3% 33.2% 61.2% 40.4% 48.9% 51.1% 23.8% 52.1% 254.8% 56.0% 38.1% 69.9% 50.0% 38.6% 76.5% 17.3% 21.7% 9.3% 34.3% 51.1% 44.9% 54.7% 56.9% 39.1% 64.4% 19.8% 60-Day 33.1% 74.5% 47.2% 81.5% 73.5% 75.9% 86.2% 58.4% 89.4% 62.1% 58.9% 26.9% 33.2% 50.3% 33.2% 61.2% 40.4% 48.9% 51.1% 23.8% 52.1% 254.8% 56.0% 38.1% 69.9% 50.0% 38.6% 76.5% 17.3% 21.7% 9.3% 34.3% 51.1% 44.9% 54.7% 56.9% 39.1% 64.4% 19.8% 52wk high 9.7% 10.0% 22.4% 36.5% 68.0% (52.5%) 57.7% 14.4% 9.5% 41.2% 44.3% (5.9%) 18.3% 2.9% 25.0% 56.3% (6.7%) 19.5% 38.7% 21.2% 8.0% 82.1% 5.1% 34.9% 44.4% 43.6% 33.9% 59.4% (42.0%) (14.2%) 5.7% 22.8% 24.4% (14.2%) (26.6%) 12.9% 28.6% 8.6% 7.4% Confidential 24

View entire presentation